Brief: Gubra Unveils UCN2 As Novel Anti-Obesity Drug Candidate For Healthy Weight Loss
17/04/2024 06:32
April 17 (Reuters) - Gubra A/S GUBRA.CO :
* GUBRA UNVEILS UCN2 AS NOVEL ANTI-OBESITY DRUG CANDIDATE
FOR
HEALTHY WEIGHT LOSS
* THIS ONCE WEEKLY PEPTIDE WILL BE DEVELOPED AS A HEALTHY
WEIGHT
LOSS DRUG WITH A FAVOURABLE CARDIAC PROFILE
Source text for Eikon: ID:nMFN5rLVqC
Further company coverage: GUBRA.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))